A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor

Clinical trial NCT06365840 · RECRUITING

Trial details

NCT number: NCT06365840
Sponsor: ImmuneOncia Therapeutics Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TMB-H Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors

Start date: 2025-01-13
Primary completion: 2027-06-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.